Dudediligence.

Monte Rosa Therapeutics, Inc

GLUENASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$5,388,227

28 notices · 278,830 sh

Oct 2025 to Oct 2026

Reported ·

$2,505,538

28 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

15 of 28 reported sales carry the 10b5-1 box. Together they are 0.16% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-07-16: MARKUS WARMUTH, Form 1442026-07-15: Champoux Jennifer, Form 1442026-06-30: FILIP JANKU, Form 1442026-06-29: FILIP JANKU, Form 1442026-06-29: ANTHONY M MANNING, Form 1442026-06-24: FILIP JANKU, Form 1442026-06-23: Champoux Jennifer, Form 1442026-06-23: FILIP JANKU, Form 1442026-06-23: EDMUND DUNN, Form 1442026-06-17: Champoux Jennifer, Form 1442026-05-01: Warmuth Markus, Form 1442026-06-01: Warmuth Markus, Form 1442026-05-29: SHARON TOWNSON, Form 1442026-05-27: Champoux Jennifer, Form 1442026-05-22: Champoux Jennifer, Form 1442026-05-21: ANTHONY M MANNING, Form 1442026-04-16: EDMUND DUNN, Form 1442026-04-14: MARKUS WARMUTH, Form 1442026-04-13: EDMUND DUNN, Form 1442026-04-09: PHILIP NICKSON, Form 1442026-04-08: EDMUND DUNN, Form 1442026-03-04: Dunn Edmund, Form 1442026-03-02: Warmuth Markus, Form 1442026-03-02: Edmund Dunn, Form 1442026-02-27: Edmund Dunn, Form 1442026-02-23: FILIP JANKU, Form 1442026-01-07: Warmuth Markus, Form 1442026-01-05: Warmuth Markus, Form 1442026-01-05: Townson Sharon, sold2026-01-05: Janku Filip, sold2026-01-05: Warmuth Markus, sold2026-01-05: Dunn Edmund, sold2026-01-05: Champoux Jennifer, sold2026-01-05: Nickson Philip, sold2026-01-07: Warmuth Markus, sold2026-02-23: Janku Filip, sold2026-02-27: Dunn Edmund, sold2026-03-02: Warmuth Markus, sold2026-03-04: Dunn Edmund, sold2026-04-09: Nickson Philip, sold2026-04-14: Warmuth Markus, sold2026-05-01: Warmuth Markus, sold2026-05-21: Manning Anthony M., sold2026-05-22: Champoux Jennifer, sold2026-05-27: Champoux Jennifer, sold2026-05-29: Townson Sharon, sold2026-06-01: Warmuth Markus, sold2026-06-17: Townson Sharon, sold2026-06-17: Champoux Jennifer, sold2026-06-23: Champoux Jennifer, sold2026-06-23: Townson Sharon, sold2026-06-23: Janku Filip, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-07-16MARKUS WARMUTH, President & CEO$220,219
9,500 shplan 2026-06-18Form 4s on file end Jun 23144 ↗
2026-07-15Champoux Jennifer, Chief Operating Officer$101,730
4,351 shplan 2026-02-19Form 4s on file end Jun 23144 ↗
2026-06-30FILIP JANKU, Chief Medical Officer$129,227
5,407 shplan 2026-03-04Form 4s on file end Jun 23144 ↗
2026-06-29FILIP JANKU, Chief Medical Officer$133,740
6,000 shplan 2026-03-04144 ↗
Form 4, 2026-06-30: sold 6,000 at $22.95 Form 4 ↗
2026-06-29ANTHONY M MANNING, Director$231,100
10,000 shno plan date144 ↗
Form 4, 2026-06-30: sold 10,000 at $23.11 Form 4 ↗
2026-06-24FILIP JANKU, Chief Medical Officer$621,300
30,000 shplan 2026-03-04Form 4s on file end Jun 23144 ↗
2026-06-23Champoux Jennifer, Chief Operating Officer$40,042
2,175 shplan 2026-02-19144 ↗
Form 4, 2026-06-25: sold 2,175 at $20.00 Form 4 ↗
2026-06-23FILIP JANKU, Chief Medical Officer$221,146
11,845 shplan 2026-03-04144 ↗
Form 4, 2026-06-25: sold 41,845 at $21.08 Form 4 ↗
2026-06-23EDMUND DUNN, Principal Accounting Officer$344,986
16,665 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-17Champoux Jennifer, Chief Operating Officer$39,005
2,176 shplan 2026-02-19144 ↗
Form 4, 2026-06-18: sold 2,176 at $19.00 Form 4 ↗
2026-06-01Warmuth Markus, President & CEO$106,253
5,466 shplan 2025-05-14144 ↗
Form 4, 2026-06-02: sold 5,466 at $19.44 Form 4 ↗
2026-05-29SHARON TOWNSON, Chief Scientific Officer$465,360
24,000 shplan 2026-02-27144 ↗
Form 4, 2026-06-01: sold 6,000 at $19.87 Form 4 ↗
2026-05-27Champoux Jennifer, Chief Operating Officer$42,043
2,175 shplan 2026-02-19144 ↗
Form 4, 2026-05-28: sold 2,175 at $20.00 Form 4 ↗
2026-05-22Champoux Jennifer, Chief Operating Officer$40,735
2,176 shplan 2026-02-19144 ↗
Form 4, 2026-05-26: sold 2,176 at $19.00 Form 4 ↗
2026-05-21ANTHONY M MANNING, Director$180,100
10,000 shno plan date144 ↗
Form 4, 2026-05-22: sold 10,000 at $18.01 Form 4 ↗
2026-05-01Warmuth Markus, President & CEO$103,447
5,467 shplan 2025-05-14144 ↗
Form 4, 2026-05-05: sold 5,467 at $18.92 Form 4 ↗
2026-04-16EDMUND DUNN, Principal Accounting Officer$345,636
18,683 shno plan dateForm 4s on file end Jun 23144 ↗
2026-04-14MARKUS WARMUTH, President & CEO$141,125
8,000 shplan 2025-05-14144 ↗
Form 4, 2026-04-15: sold 8,000 at $17.64 Form 4 ↗
2026-04-13EDMUND DUNN, Principal Accounting Officer$300,366
16,687 shno plan dateForm 4s on file end Jun 23144 ↗
2026-04-09PHILIP NICKSON, Chief Business & Legal Officer$103,413
5,845 shno plan date144 ↗
Form 4, 2026-04-10: sold 5,845 at $17.69 Form 4 ↗
2026-04-08EDMUND DUNN, Principal Accounting Officer$450,623
26,117 shno plan dateForm 4s on file end Jun 23144 ↗
2026-03-04Dunn Edmund, Principal Accounting Officer$2,482
139 shno plan date144 ↗
Form 4, 2026-03-05: sold 139 at $17.96 Form 4 ↗
2026-03-02Warmuth Markus, President & CEO$97,974
5,466 shplan 2025-05-14144 ↗
Form 4, 2026-03-04: sold 5,466 at $17.92 Form 4 ↗
2026-03-02Edmund Dunn, Principal Accounting Officer$9,380
536 shno plan dateno Form 4 on file144 ↗
2026-02-27Edmund Dunn, Principal Accounting Officer$455,506
25,164 shno plan date144 ↗
Form 4, 2026-03-02: sold 25,700 at $18.09 Form 4 ↗
2026-02-23FILIP JANKU, Chief Medical Officer$179,161
9,189 shno plan date144 ↗
Form 4, 2026-02-24: sold 9,189 at $19.50 Form 4 ↗
2026-01-07Warmuth Markus, President & CEO$128,372
5,466 shplan 2025-05-14144 ↗
Form 4, 2026-01-09: sold 5,466 at $23.48 Form 4 ↗
2026-01-05Warmuth Markus, President & CEO$153,759
10,135 shplan 2025-05-14144 ↗
Form 4, 2026-01-05: sold 10,135 at $15.17 Form 4 ↗